Invesco Biotechnology & Genome ETF (PBE) Chart & Stock Price History $70.71 +0.04 (+0.06%) Closing price 04:10 PM EasternExtended Trading$70.76 +0.05 (+0.07%) As of 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Biotechnology & Genome ETF Stock Price Performance The Invesco Biotechnology & Genome ETF (PBE) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has increased 1.07%, with a year-to-date return of 6.28%. In the past month, the fund has increased 0.83%, reflecting recent market activity. As of the latest close, Invesco Biotechnology & Genome ETF traded at $70.67 with a market cap of $221.90 million and volume of 3,786 shares. Five years ago, the fund traded at $61.46, representing a 15.05% increase over that period. At the time, it had a market cap of $236.62 million and a volume of 2,843 shares. Receive PBE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-1.17%1 Month Performance+0.83%3 Month Performance+5.68%Year-To-Date Performance+6.28%1 Year Performance+1.07%5 Year Performance+15.05% PBE Stock Chart for Tuesday, October, 14, 2025 PBE Chart by TradingView Invesco Biotechnology & Genome ETF Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/14/2025$70.67$70.71+0.06%$70.92$70.012,102 shs$222.03 million10/13/2025$70.36$70.67+0.44%$70.87$70.223,786 shs$221.90 million10/10/2025$71.55$70.36-1.66%$71.68$70.297,733 shs$220.93 million10/09/2025$72.05$71.55-0.69%$72.04$71.532,514 shs$224.67 million10/08/2025$71.93$72.05+0.17%$72.44$72.054,508 shs$226.24 million10/07/2025$72.56$71.93-0.87%$72.66$71.895,048 shs$225.86 million10/06/2025$72.71$72.56-0.21%$73.03$72.367,237 shs$227.84 million10/03/2025$72.01$72.71+0.97%$72.93$72.207,645 shs$229.76 million10/02/2025$71.64$72.01+0.52%$72.03$71.504,695 shs$248.44 million10/01/2025$69.87$71.64+2.53%$71.79$69.954,726 shs$247.16 million Get the Latest News and Ratings for PBE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. 09/30/2025$69.15$69.87+1.04%$70.03$68.753,543 shs$241.05 million09/29/2025$68.58$69.15+0.83%$69.15$68.843,477 shs$238.57 million09/26/2025$67.85$68.58+1.08%$68.58$68.113,392 shs$236.60 million09/25/2025$69.14$67.85-1.87%$68.91$67.695,649 shs$234.08 million09/24/2025$69.91$69.14-1.10%$69.65$68.884,231 shs$238.53 million09/23/2025$70.37$69.91-0.65%$70.43$69.883,796 shs$241.19 million09/22/2025$70.52$70.37-0.21%$70.71$70.204,615 shs$242.78 million09/19/2025$71.03$70.52-0.72%$71.19$70.523,932 shs$243.29 million09/18/2025$69.57$71.03+2.10%$71.03$69.966,559 shs$245.05 million09/17/2025$69.68$69.57-0.16%$70.08$69.573,505 shs$240.02 million09/16/2025$69.60$69.68+0.11%$69.73$69.495,358 shs$240.40 million09/15/2025$70.13$69.60-0.76%$70.01$69.385,253 shs$240.12 million Related Companies CURE Stock Chart PJP Stock Chart XPH Stock Chart PINK Stock Chart PSCH Stock Chart XHE Stock Chart KURE Stock Chart PTH Stock Chart BBH Stock Chart SBIO Stock Chart Receive PBE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:PBE) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredWhat the hell is going on, America?America’s $37.5 trillion debt spiral, soaring deficits, and repeated credit downgrades are exactly what Porter...Porter & Company | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
